On 2025-11-24, NervGen Pharma Corp. (V.NGE) announced earnings per share of -0.06 for the fiscal quarter ending 2025-09-30, beating the average analyst estimate of -0.13.

The next expected annoucement date for quarterly earnings is 2026-02-23, with an average estimated earnings per share of -0.10 for the fiscal quarter ending 2025-12-31.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.